Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
General Info
Time period covered
January, 2013 - December, 2015
Data type
Scientific literature
Keywords
Citation
Journal
Int J Cancer
Pages
2771-80
Publication year
2016
Suggested citation
Simms KT, Smith MA, Lew JB, Kitchener HC, Castle PE, Canfell K. Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. Int J Cancer. 2016; 139(12): 2771-80.